The technology company’s shares were up 4.33% in pre-market trading after the results.

The U.S. health insurer, a top provider of the government-backed healthcare insurance for adults aged 65 and older, projected ...

Looking ahead, Emerson provided an optimistic outlook for fiscal 2026, forecasting adjusted earnings per share of $6.35 to $6.55, above the analyst consensus of $6.00. The company expects underlying ...

Investing.com -- Biohaven (NYSE:BHVN) stock fell 44% after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the company’s New Drug Application for VYGLXIA ...

Despite the earnings beat, Perrigo lowered its full-year 2025 outlook, now expecting adjusted earnings of $2.70 to $2.80 per share, below the previous analyst consensus of $2.98. The company also ...

Investing.com -- Japanese pharmaceutical company Eisai reported a 66% year-on-year increase in first-half operating profit to ¥34.4 billion, falling short of analyst expectations of ¥38 billion.

The rapid growth marks a dramatic shift from last year when BYD registered only 8,788 cars in the UK, with Tesla outselling the Chinese manufacturer by an almost 6-to-1 margin. This transformation has ...

Investing.com -- Microsoft and Abu Dhabi’s G42 announced a 200-megawatt expansion of data center capacity in the United Arab Emirates on Wednesday, as part of an over $15 billion investment commitment ...

Despite the headwinds, Owens Corning maintained strong margins, with adjusted EBITDA margin from continuing operations at 24%, though down from 26% in the same period last year. The company generated ...

Investing.com -- German carmaker BMW expects its sales in China to remain flat in 2026 compared to this year’s levels, with growth from its new electric vehicle lineup not anticipated until 2027. "We ...